Speaker illustration

Associate Professor Albert Wiegman

Amsterdam University Medical Centre, Amsterdam (Netherlands (The))

Member of:

European Society of Cardiology
European Society of Cardiology

Albert Wiegman, born in Amsterdam, the Netherlands, became a pediatrician and member of the staff at the Amsterdam University Medical Centers in 1991. In 1993, he completed his sub-specialization in pediatric cardiology. In that year, the pediatric-lipid department came under his care. He started his research into the treatment of familial hypercholesterolemia in children, in close co-operation with prof John JP Kastelein, head of the department of vascular medicine. He brought the research to completion in his thesis: 'Pediatric implications of heterozygous Familial Hypercholesterolemia'. In 2020, he was appointed associate professor and principal investigator.

Evolocumab treatment reduces carotid intima-media thickness in paediatric patients with heterozygous familial hypercholesterolaemia

Event: ESC Congress 2022

Topic: Drug therapy

Session: Optimal risk factor therapy in high risk patients


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb